Adjusting to a new time zone or work schedule can leave the body's internal clock out of sync for days, contributing to sleep disruption, metabolic changes and other health consequences. Researchers at Rice University and Northwestern University have developed an implantable cell therapy that may help the body adapt more quickly to these disruptions.
In a recent study titled "Encapsulated Leptin-Producing Cells Facilitate Entrainment of Circadian Rhythms in Rodents and Nonhuman Primates," encapsulated cells engineered to continuously produce the metabolic hormone leptin reduced the time required for animals to adjust to shifts in the light-dark cycle that mimic jet lag and shift work. Published in Advanced Science, the study's findings demonstrate a new approach to regulating circadian rhythms through metabolic signaling and provide early evidence that engineered cell therapies could be used to address circadian disruption.
A temporary metabolic nudge
"Current approaches for adjusting circadian rhythms rely heavily on precisely timed behaviors such as light exposure, meal schedules or melatonin administration," said Omid Veiseh, professor of bioengineering at Rice. "We wanted to explore whether a temporary cell therapy could provide a more practical way to help the body adapt to changing schedules."
The therapy consists of human retinal pigment epithelial cells engineered to produce leptin, a hormone best known for regulating appetite and metabolism. The cells are encapsulated within microscopic alginate spheres that protect them from the immune system while allowing therapeutic proteins to diffuse into the body. Following a simple subcutaneous injection, the encapsulated cells temporarily elevate circulating leptin levels before naturally losing viability over time.
"Metabolism and circadian rhythms are closely connected, but the therapeutic potential of that relationship remains largely unexplored," said Martha Hotz Vitaterna, professor of neurobiology at Northwestern University and co-corresponding author on the study. "These findings suggest that metabolic signals can be leveraged to accelerate adaptation to circadian disruptions."
Faster adjustment across species
In mouse studies, animals receiving the leptin-producing cell therapy adjusted significantly faster following both phase advances and phase delays in the light-dark cycle. Mice treated with the therapy adapted to a four-hour schedule delay 50% faster than control animals.
Source: Phys.org
@EverythingScience
